Skip to main content
Clinical Trials/NCT02224638
NCT02224638CompletedPhase 4

Evaluation of Wound Management for Sacral Pressure Ulcers With Necrotic Tissue

Medline Industries2 sites in 1 country21 target enrollmentStarted: December 1, 2014Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 4
Status
Completed
Sponsor
Enrollment
21
Locations
2
Primary Endpoint
Percentage of Wounds Healed

Study Overview

Brief Summary

Evaluation of a wound care debridement product and a moisturizer on sacral pressure ulcer wounds

Detailed Description

Pressure ulcers on the sacral area will be applied with either a wound debridement product or a wound moisturizer product plus a gentle wound dressing to manage wound closure over a 2-3 week period of treatment.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Male or female subjects of any age
  • •Sacral wounds with necrotic tissue

Exclusion Criteria

  • •3rd degree burns
  • •know hypersensitivity to products

Arms & Interventions

TheraHoney HD

Active Comparator

Honey product

Intervention: TheraHoney HD (Device)

SkinTegrity

Active Comparator

Skin moisturizer

Intervention: SkinTegrity (Device)

Outcomes

Primary Outcomes

Percentage of Wounds Healed

Time Frame: 3 weeks

Percentage of wounds that were complete or partially healed with either treatment measured by change in wound size of sacral pressure ulcer

Secondary Outcomes

  • Number of Participants With Adverse Events(3 weeks)

Investigators

Sponsor
Medline Industries
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials